← Back to Search

Cockroach Reduction Intervention for Childhood Asthma (ARCHS Trial)

Led By Felicia Rabito, PhD
Research Sponsored by Tulane University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Either on a long term controller medication for asthma, or have asthma symptoms 3 or more days per week over the past 2 weeks or nighttime asthma symptoms at least 3 times in the past month
Age 5 - 17 years with uncontrolled persistent asthma
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3, 6, 9, 12 months
Awards & highlights

ARCHS Trial Summary

This trial is testing a cockroach reduction intervention to improve patient-centered asthma outcomes.

Who is the study for?
The ARCHS trial is for children aged 5-17 in the Greater New Orleans area with uncontrolled persistent asthma and exposure to cockroaches. They must have had recent hospital visits or symptoms due to asthma, sleep at the target home most of the week, and speak English or Spanish. Kids can't join if they smoke, take beta-blockers, have certain heart diseases (except hypertension), other serious illnesses requiring daily meds, are on immunotherapy, or plan to move soon.Check my eligibility
What is being tested?
This study tests two ways to reduce cockroach allergens in homes of asthmatic kids: one group uses insecticidal bait while another follows a tailored approach. The goal is to see which method better improves asthma-related health outcomes like symptom days, control over asthma, healthcare use and overall quality of life over a year.See study design
What are the potential side effects?
Since this trial involves environmental interventions rather than medications, direct side effects from treatments are minimal. However, there may be indirect effects related to changes in household pest populations.

ARCHS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
I have asthma and need daily medication or have frequent symptoms.
I am between 5 and 17 years old with asthma that isn't well-controlled.
I've been hospitalized overnight for asthma recently or had emergency visits twice last year.

ARCHS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3, 6, 9, 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3, 6, 9, 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Level of Asthma control
Maximum number of symptom days in the previous two weeks
Number of participants with an asthma related hospitalization, unscheduled clinic or emergency room visit for asthma in the previous month
Secondary outcome measures
Asthma quality of life
Cockroach exposure

ARCHS Trial Design

2Treatment groups
Active Control
Group I: Comparator 1 (tailored approach)Active Control1 Intervention
Multi-component intervention tailored to the participant's allergic profile.
Group II: Comparator 2 (insecticidal bait)Active Control1 Intervention
Insecticidal bait for cockroach reduction.

Find a Location

Who is running the clinical trial?

Patient-Centered Outcomes Research InstituteOTHER
549 Previous Clinical Trials
29,996,258 Total Patients Enrolled
Tulane UniversityLead Sponsor
115 Previous Clinical Trials
226,212 Total Patients Enrolled
Felicia Rabito, PhD4.146 ReviewsPrincipal Investigator - Tulane University School of Public Health and Tropical Medicine
Tulane University
5Patient Review
Dr. Rabito is truly impressive! His intelligence is unmatched, and he makes sure to spend quality time with each patient. Even if he runs late, he is always apologetic. I would gladly wait hours to see him again!

Media Library

Comparator 1 (tailored approach) Clinical Trial Eligibility Overview. Trial Name: NCT04331353 — N/A
Childhood Asthma Research Study Groups: Comparator 1 (tailored approach), Comparator 2 (insecticidal bait)
Childhood Asthma Clinical Trial 2023: Comparator 1 (tailored approach) Highlights & Side Effects. Trial Name: NCT04331353 — N/A
Comparator 1 (tailored approach) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04331353 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who is eligible to take part in this clinical research?

"Qualified applicants must have asthma and be between the ages of 5 to 17. The trial is aiming to enroll 290 participants in total."

Answered by AI

Is this research endeavor accepting participants aged 40 or above?

"According to the requirements listed on this trial, potential participants must range between 5 and 17 years old. There are 121 studies available for younger individuals and 199 for people over 65."

Answered by AI

What is the cap on the number of participants in this experiment?

"Accurate, the details posted on clinicaltrials.gov affirms that this trial is currently accepting volunteers. This medical experiment was first published on November 15th 2021 and last modified on March 21st 2022. The study needs to recruit 290 individuals from 1 sites."

Answered by AI

Are there vacancies for participants in this trial?

"Per clinicaltrials.gov, this trial has been recruiting subjects since its launch on November 15th 2020 and is still open for enrolment as of March 21st 2022."

Answered by AI
~66 spots leftby Apr 2025